Transgenic overexpression of pregnancy-associated plasma protein-A increases the somatic growth and skeletal muscle mass in mice

Endocrinology

Volumn 148, Issue 12, 2007, Pages 6176-6185

  Rehage, Mark ^a   Mohan, Subburaman ^a,b   Wergedal, Jon E ^a,b   Bonafede, Blake ^a   Tran, Kiet ^a   Hou, Diana ^a   Phang, David ^a   Kumar, Ashok ^a,b,d   Qin, Xuezhong ^a,b,c  

^a LOMA LINDA UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Jerry L Pettis Memorial VA Medical Center   (United States)

^d University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BODY GROWTH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; IN VIVO STUDY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE MASS; MYOBLAST; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; TRANSGENIC MOUSE; WILD TYPE;

ABSORPTIOMETRY, PHOTON; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BODY WEIGHT; CELL LINE; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOBLOTTING; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MYOBLASTS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SOMATOMEDINS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36348965426     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0274     Document Type: Article

References (43)

1. Rosenberg IH 1997 Sarcopenia: origins and clinical relevance. J Nutr 127:990S-991S
2. Roubenoff R 1999 The pathophysiology of wasting in the elderly. J Nutr 129:256S-259S
3. Lamberts SW, van den Beld AW, van der Lely AJ 1997 The endocrinology of aging. Science 278:419-424
4. Bross R, Javanbakht M, Bhasin S 1999 Anabolic interventions for aging-associated sarcopenia. J Clin Endocrinol Metab 84:3420-3430
5. Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton 3rd LJ, Khosla S 2004 A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J Bone Miner Res 19:1075-1083
6. Idiculla J, Shirazi N, Opacka-Juffry J, Ganapathi 2004 Diabetic amyotrophy: a brief review. Natl Med J India 17:200-202
7. Bolton CF 1993 Neuromuscular complications of sepsis. Intensive Care Med 19(Suppl 2):S58-S63
8. Mitch WE, Goldberg AL 1996 Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335:1897-1905
9. Charge SB, Rudnicki MA 2004 Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238
10. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517
11. Shavlakadze T, Winn N, Rosenthal N, Grounds MD 2005 Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm IGF Res 15:4-18
12. Rosen CJ, Donahue LR, Hunter SJ 1994 Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med 206:83-102
13. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
14. Mohan S, Baylink DJ 2002 IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19-31
15. Haugk KL, Wilson HM, Swisshelm K, Quinn LS 2000 Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF. Endocrinology 141:100-110
16. Xi G, Kamanga-Sollo E, Pampusch MS, White ME, Hathaway MR, Dayton WR 2004 Effect of recombinant porcine IGFBP-3 on IGF-I and long-R3-IGFI-stimulated proliferation and differentiation of L6 myogenic cells. J Cell Physiol 200:387-394
17. Ewton DZ, Coolican SA, Mohan S, Chernausek SD, Florini JR 1998 Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J Cell Physiol 177:47-57
18. Gustafsson T, Andersson P, Arnqvist HJ 1999 Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells. J Endocrinol 161:245-253
19. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates 3rd JR, Conover CA 1999 The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153
20. Byun D, Mohan S, Yoo M, Sexton C, Baylink DJ, Qin X 2001 Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab 86:847-854
21. Monget P, Mazerbourg S, Delpuech T, Maurel MC, Maniere S, Zapf J, Lalmanach G, Oxvig C, Overgaard MT 2003 Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol Reprod 68:77-86
22. Lin TM, Galbert SP, Kiefer D, Spellacy WN, Gall S 1974 Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 118:223-236
23. Oxvig C, Haaning J, Kristensen L, Wagner JM, Rubin I, Stigbrand T, Gleich GJ, Sottrup-Jensen L 1995 Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma. J Biol Chem 270:13645-13651
24. Sivanandam AS, Mohan S, Kapur S, Kita H, Lau KH, Bagi G, Baylink DJ, Qin X 2004 Covalent interaction between proform of eosinophil major basic protein (proMBP) and pregnancy-associated plasma protein-A (PAPP-A) is a cell-mediated event and required for proMBP inhibition of the catalytic activity of PAPP-A. Arch Biochem Biophys 423:343-350
25. Kristensen T, Oxvig C, Sand O, Moller NP, Sottrup-Jensen L 1994 Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry 33:1592-1598
26. Kumar A, Mohan S, Newton J, Rehage M, Tran K, Baylink DJ, Qin X 2005 Pregnancy-associated plasma protein-A regulates myoblast proliferation and differentiation through an insulin-like growth factor-dependent mechanism. J Biol Chem 280:37782-37789
27. Qin X, Strong DD, Baylink DJ, Mohan S 1998 Structure-function analysis of the human insulin-like growth factor binding protein-4. J Biol Chem 273:23509-23516
28. Stuart A, McComas AJ, Dean D 1983 Restoration of functional continuity in dystrophic murine muscle after crushing. Exp Neurol 81:153-157
29. Stabnov L, Kasukawa Y, Guo R, Amaar Y, Wergedal JE, Baylink DJ, Mohan S 2002 Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice. Bone 30:909-916
30. Li X, Mohan S, Gu W, Baylink DJ 2001 Analysis of gene expression in the wound repair/regeneration process. Mamm Genome 12:52-59
31. Parsons SA, Wilkins BJ, Bueno OF, Molkentin JD 2003 Altered skeletal muscle phenotypes in calcineurin Aα and Aβ gene-targeted mice. Mol Cell Biol 23:4331-4343
32. Qin X, Wergedal JE, Rehage M, Tran K, Newton J, Lam P, Baylink DJ, Mohan S 2006 Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology 147:5653-5661
33. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
34. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
35. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ 1995 Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116
36. Oliver WT, Rosenberger J, Lopez R, Gomez A, Cummings KK, Fiorotto ML 2005 The local expression and abundance of IGF binding proteins in skeletal muscle are regulated by age and gender, but not local IGF-I in vivo. Endocrinology 146:5455-5462
37. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N 2001 Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200
38. Shimasaki S, Shimonaka M, Zhang HP, Ling N 1991 Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266:10646-10653
39. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J, Pintar JE 2006 Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol Endocrinol 20:2173-2186
40. Bischof P, Geinoz A, Herrmann WL, Sizonenko PC 1984 Pregnancy-associated plasma protein A (PAPP-A) specifically inhibits the third component of human complement (C3). Placenta 5:1-7
41. Sinosich MJ, Zakher A 1991 Pregnancy-associated plasma protein A interaction with heparin: a critical appraisal. Gynecol Obstet Invest 32:72-77
42. Boldt HB, Overgaard MT, Laursen LS, Weyer K, Sottrup-Jensen L, Oxvig C 2001 Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem J 358:359-367
43. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer EM, Oxvig C, van Deursen J 2004 Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131:1187-1194